Nebula Research & Development LLC Atri Cure, Inc. Transaction History
Nebula Research & Development LLC
- $464 Billion
- Q1 2024
A detailed history of Nebula Research & Development LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 15,579 shares of ATRC stock, worth $354,733. This represents 0.1% of its overall portfolio holdings.
Number of Shares
15,579Holding current value
$354,733% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding ATRC
# of Institutions
237Shares Held
46.7MCall Options Held
95.7KPut Options Held
119K-
Vanguard Group Inc Valley Forge, PA4.75MShares$108 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.23MShares$96.3 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.65MShares$83.2 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.68MShares$61 Million0.48% of portfolio
-
Wellington Management Group LLP Boston, MA1.64MShares$37.3 Million0.01% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.06B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...